ALDX - Aldeyra Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development16,302.56813,175.677,574.3983,707.544
Selling General and Administrative6,185.825,520.3084,414.7093,563.046
Non Recurring----
Others----
Total Operating Expenses22,488.38818,695.97811,989.1077,270.59
Operating Income or Loss-22,488.388-18,695.978-11,989.107-7,270.59
Income from Continuing Operations
Total Other Income/Expenses Net147.799-3.472-101.182,083.331
Earnings Before Interest and Taxes-22,488.388-18,695.978-11,989.107-7,270.59
Interest Expense-113.453-105.509-112.306-244.174
Income Before Tax-22,340.589-18,699.45-12,090.287-5,187.259
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-22,340.589-18,699.45-12,090.287-5,187.259
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-22,340.589-18,699.45-12,090.287-5,187.259
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-22,340.589-18,699.45-12,090.287-9,573.911